Loading clinical trials...
Loading clinical trials...
Growth and Feeding Tolerance of Infants Consuming a Formula Supplemented With Human Milk Oligosaccharides (HMOs): An Uncontrolled, Open-label, Prospective Study
Conditions
Interventions
HMO Supplemented Infant Formula
Locations
4
Pakistan
Quaid E Azam Medical College
Chak Four Hundred Fifty-four, Pakistan
Liaqat National Hospital
Karachi, Pakistan
Fatima Memorial Hospital
Lahore, Pakistan
Khawaja Muhammad Safdar Medical College
Sialkot, Pakistan
Start Date
July 29, 2021
Primary Completion Date
December 15, 2022
Completion Date
December 15, 2022
Last Updated
December 24, 2025
NCT03050268
NCT07015203
NCT06513026
NCT07286747
NCT05735080
NCT07440342
Lead Sponsor
Société des Produits Nestlé (SPN)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions